PT93984A - Processo para a preparacao de derivados piridazinona - Google Patents

Processo para a preparacao de derivados piridazinona

Info

Publication number
PT93984A
PT93984A PT93984A PT9398490A PT93984A PT 93984 A PT93984 A PT 93984A PT 93984 A PT93984 A PT 93984A PT 9398490 A PT9398490 A PT 9398490A PT 93984 A PT93984 A PT 93984A
Authority
PT
Portugal
Prior art keywords
compounds
pyrido
pyridazine
oxo
substituted
Prior art date
Application number
PT93984A
Other languages
English (en)
Other versions
PT93984B (pt
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT93984A publication Critical patent/PT93984A/pt
Publication of PT93984B publication Critical patent/PT93984B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PT93984A 1989-05-11 1990-05-09 Processo para a preparacao de derivados piridazinona PT93984B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,417 US4996204A (en) 1989-05-11 1989-05-11 Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Publications (2)

Publication Number Publication Date
PT93984A true PT93984A (pt) 1991-01-08
PT93984B PT93984B (pt) 1996-11-29

Family

ID=23376622

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93984A PT93984B (pt) 1989-05-11 1990-05-09 Processo para a preparacao de derivados piridazinona

Country Status (18)

Country Link
US (1) US4996204A (pt)
EP (1) EP0401981B1 (pt)
JP (1) JPH0631235B2 (pt)
KR (1) KR920003559B1 (pt)
AT (1) ATE121743T1 (pt)
AU (1) AU611610B2 (pt)
CA (1) CA2016326C (pt)
DE (1) DE69018876T2 (pt)
DK (1) DK0401981T3 (pt)
ES (1) ES2071016T3 (pt)
FI (1) FI93013C (pt)
HU (1) HU206714B (pt)
IE (1) IE66029B1 (pt)
IL (1) IL94302A (pt)
NO (1) NO173938C (pt)
NZ (1) NZ233599A (pt)
PT (1) PT93984B (pt)
ZA (1) ZA903564B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5716954A (en) * 1991-10-09 1998-02-10 Syntex U.S.A. Inc. Benzopyridazinone and pyridopyridazinone compounds
WO1994007867A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
AP2000001929A0 (en) 1998-03-31 2000-09-30 Inst For Pharm Discovery Inc Substituted indolealkanoic acids.
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
AP2001002359A0 (en) * 2000-11-30 2001-12-31 Pfizer Prod Inc Combination of gaba agonists and aldose reductase inhibitors.
ES2240657T3 (es) 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
GEP20053675B (en) * 2001-03-30 2005-11-25 Pfizer Prod Inc Pyridazinone Aldose Reductase Inhibitors
JP2004528344A (ja) * 2001-04-30 2004-09-16 ファイザー・プロダクツ・インク アルドースレダクターゼ阻害薬とシクロオキシゲナーゼ−２阻害薬の併用
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
US12653825B2 (en) 2010-07-16 2026-06-16 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
HUE031506T2 (en) * 2010-07-16 2017-07-28 Univ Columbia Aldose reductase inhibitors and their use
ES2966094T3 (es) 2016-06-21 2024-04-18 Univ Columbia Compuestos 4-oxo-3,4-dihidrotieno[3,4-d]piridazina como inhibidores de la aldosa reductasa y métodos de uso de los mismos
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
CN113840825A (zh) 2019-04-01 2021-12-24 应用治疗公司 醛糖还原酶抑制剂
MX2021013511A (es) 2019-05-07 2022-02-23 Univ Miami Tratamiento y deteccion de neuropatias heredadas y trastornos asociados.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2708187A1 (de) * 1977-02-25 1978-08-31 Thomae Gmbh Dr K Neue pyrido-pyridazin-one
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
CA1160518A (en) * 1979-07-06 1984-01-17 E. I. Du Pont De Nemours And Company Coated cookware with fep topcoat
IL80475A (en) * 1985-11-07 1993-01-31 Pfizer Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Also Published As

Publication number Publication date
DE69018876D1 (de) 1995-06-01
EP0401981A1 (en) 1990-12-12
FI902335A0 (fi) 1990-05-10
NO902070D0 (no) 1990-05-10
KR920003559B1 (ko) 1992-05-04
ZA903564B (en) 1992-08-26
IE901701L (en) 1990-11-11
AU611610B2 (en) 1991-06-13
ES2071016T3 (es) 1995-06-16
JPH0631235B2 (ja) 1994-04-27
PT93984B (pt) 1996-11-29
NO902070L (no) 1990-11-12
IL94302A (en) 1994-01-25
HU206714B (en) 1992-12-28
CA2016326A1 (en) 1990-11-11
HUT54683A (en) 1991-03-28
US4996204A (en) 1991-02-26
EP0401981B1 (en) 1995-04-26
HU902996D0 (en) 1990-09-28
IL94302A0 (en) 1991-03-10
DK0401981T3 (da) 1995-09-04
FI93013B (fi) 1994-10-31
ATE121743T1 (de) 1995-05-15
CA2016326C (en) 1995-05-30
NZ233599A (en) 1991-07-26
NO173938C (no) 1994-02-23
DE69018876T2 (de) 1995-08-24
AU5490590A (en) 1990-11-15
NO173938B (no) 1993-11-15
FI93013C (fi) 1995-02-10
KR900018092A (ko) 1990-12-20
JPH035481A (ja) 1991-01-11
IE66029B1 (en) 1995-11-29

Similar Documents

Publication Publication Date Title
DE69018876D1 (de) Pyridazinon-Derivate.
GR3000854T3 (en) Indolinone derivatives
PT91931A (pt) Processo de preparacao de derivados de acido fenilalcanoico e de composicoes farmaceuticas que os contem
GR3003548T3 (pt)
PT101077A (pt) Processo para a preparacao de derivados de tiazolidinodiona susbtituidos
DE3071230D1 (en) Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-r trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them
NO178025C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater
IE801005L (en) Benzimidazolones.
HUT62855A (en) Process for producing glycerol derivatives and pharmaceutical compositions comprising same
AU3077289A (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
PT91427A (pt) Processo para a preparacao de composicoes farmaceuticas contendo carbinoloimidazois anti-inflamatorios
RU1831477C (ru) Способ получени производных 1,4-дигидропиридинов или их фармацевтически приемлемых солей

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960829

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000229